Brian Donnelly

Brian Donnelly has served as the Chief Commercial Officer at Myriad Genetics since May 2025, where he oversees global commercial strategy and execution across all business units, including marketing, sales, product management, business development, and customer experience. He brings over 20 years of leadership experience across diagnostics, genomics, and consumer health, with prior roles at Ancestry, Amazon, Illumina, and GlaxoSmithKline. Recognized by Forbes as one of the Top 50 Most Entrepreneurial CMOs in 2025, Mr. Donnelly serves on corporate and advisory boards and holds an MBA and J.D. from Rutgers University.